MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Factors Correlated With Life Satisfaction in Mexican Parkinson’s disease Patients

    A. Almaraz-Espinoza, E. Velazquez-Avila, P. Bazan-Rodriguez, A. Banegas-Lagos, A. Cervantes-Arriaga, M. Rodriguez-Violante, D. Martinez-Ramirez (Monterrey, Mexico)

    Objective: To identify factors correlated with life satisfaction among patients with Parkinson’s disease in Mexico. Background: Parkinson's disease motor and non-motor symptoms have been the…
  • MDS Virtual Congress 2020

    Sleep Patterns in Relation to Disease Severity in Parkinson’s Disease: A Study of 84 Ibadan Patients

    R. Oguntoye (Ibadan, Nigeria)

    Objective: To assess the sleep patterns in relation to disease severity. Background: Parkinson’s disease is a progressive neurodegenerative disease. The non-motor symptoms are said to…
  • MDS Virtual Congress 2020

    Is Chronotype a biomarker for depression in military Veterans with Parkinson’s disease?

    A. Sarwar (Houston, TX, TX, USA)

    Objective: To determine the association of different chronotypes with depression in military Veterans with Parkinson's disease (PD). Background: Depression is a common non-motor symptom in…
  • MDS Virtual Congress 2020

    Vascular factors in Parkinson’s disease with cognitive impairment

    H.L Wang, YY. Gao, L.J Wang (Guangzhou, China)

    Objective: To review the relationship between vascular related factors and cognitive impairment in Parkinson's disease. Background: Parkinson's disease is a chronic, progressive, neurodegenerative disease that…
  • MDS Virtual Congress 2020

    Maladaptive motor cortex plasticity off medication in Parkinson’s disease patients with levodopa-induced dyskinesias

    M. Dileone, C. Ammann, V. Catanzaro, R. Piredda, M.G Monje, I. Navalpotro-Gómez, A. Bergareche, L. Vela, F. Alonso-Frech, M.J Catalán-Alonso, J.A Molina, N. López-Ariztegui, F. Hernández-Fernández, B. Fernández-Rodríguez, C. Gasca-Salas, J.U Máñez-Miró, R. Martínez-Fernández, A. Sánchez-Ferro, A. Oliviero, J.A Obeso, G. Foffani (Móstoles, Spain)

    Objective: To test the hypothesis that motor cortex plasticity is maladaptive in Parkinson's disease (PD) patients suffering from dyskinesias, as compared to non-dyskinetic patients. Background:…
  • MDS Virtual Congress 2020

    An agent-based model replicates the pathogenic spread of alpha-synuclein in mice

    S. Rahayel, B. Mišić, Y.Q Zheng, Z.Q Liu, A. Caputo, K. Luk, A. Dagher (Montreal, QC, Canada)

    Objective: To investigate the ability of a susceptible-infected-removed (SIR) agent-based model to predict the pathogenic spread of alpha-synuclein fibrils after injection in mice. Background: Parkinson’s…
  • MDS Virtual Congress 2020

    Improving Diagnosis and Treatment of Anxiety in Parkinson’s Disease: IDATA-PD Study Update

    N. Dissanayaka, G. Byrne, L. Mitchell, J. O'Sullivan, A. Padmassini, E. White, J. Yang, E. Forbes, K. Thangavelu, T. Au, A. Lehn, R. Adam, N. Pachana (Brisbane, Australia)

    Objective: 1. To develop an inventory to assess Parkinson’s disease (PD) specific anxiety for person centred psychotherapy interventions. 2. To develop manualised cognitive behaviour therapy…
  • MDS Virtual Congress 2020

    Risk of Suicidal Ideation After Deep Brain Stimulation Surgery in Patients with Parkinson’s Disease

    A. Seritan, J. Parad, S. Wang, J. Ostrem, A.M Iosif (San Francisco, CA, USA)

    Objective: To explore the association of preoperative risk factors with postoperative suicidal ideation in patients with Parkinson’s disease (PD) who had deep brain stimulation (DBS)…
  • MDS Virtual Congress 2020

    Phase I-II first-in-human clinical trial of intraputamenal CDNF in Parkinson’s disease: Topline results of the six-month double-blind placebo-controlled main study and the six-month active treatment extension study

    S. Booms, H. Huttunen, J. Koskinen, M. Sjögren, M. Saarma, M. Woolley, B. Murphy, P. Fielder, J. Baker, P. Skinner, J. Rinne, A. Varrone, M. Andreasson, G. Paul-Visse, R. Kivisaari, H. Bjartmarz, G. Lind, P. Almqvist, F. Scheperjans, H. Widner, P. Svenningsson (Espoo, Finland)

    Objective: To assess the safety and tolerability and to explore the preliminary efficacy of intermittent intraputamenal monthly infusions of CDNF in subjects with advanced idiopathic…
  • MDS Virtual Congress 2020

    The Levodopa in Early Parkinson’s disease (LEAP) study: Post-hoc analyses

    H. Frequin, J. Schouten, R. de Bie, L. LEAP-study group (Amsterdam, Netherlands)

    Objective: We present the results of several post hoc analyses of the LEAP-study. Background: Among patients with Parkinson’s disease who were evaluated in the LEAP-study…
  • « Previous Page
  • 1
  • …
  • 95
  • 96
  • 97
  • 98
  • 99
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley